First Time Loading...
S

Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 17.92 CNY -0.78% Market Closed
Updated: May 5, 2024

Shanghai Pharmaceuticals Holding Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Pharmaceuticals Holding Co Ltd
Revenue Peer Comparison

Comparables:
1099
600998
C
600511
000963
C
000028

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Revenue
¥260.3B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
13%
Sinopharm Group Co Ltd
HKEX:1099
Revenue
¥591.6B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
15%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Revenue
¥151.8B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
17%
C
China National Medicines Corp Ltd
SSE:600511
Revenue
¥49.7B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
17%
Huadong Medicine Co Ltd
SZSE:000963
Revenue
¥40.3B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
10%
C
China National Accord Medicines Corp Ltd
SZSE:000028
Revenue
¥75.5B
CAGR 3-Years
8%
CAGR 5-Years
12%
CAGR 10-Years
14%

See Also

What is Shanghai Pharmaceuticals Holding Co Ltd's Revenue?
Revenue
260.3B CNY

Based on the financial report for Dec 31, 2023, Shanghai Pharmaceuticals Holding Co Ltd's Revenue amounts to 260.3B CNY.

What is Shanghai Pharmaceuticals Holding Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
13%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been 11% over the past three years , 10% over the past five years , and 13% over the past ten years .